TABLE 2 Survival related to score on the International Prognostic Scoring System
From the following article:
Methylation inhibitor therapy in the treatment of myelodysplastic syndrome
Lewis R Silverman and Ghulam J Mufti
BACK TO ARTICLE| Risk groupa | Score | Median survival (years) |
|---|---|---|
aSee Table 1 for explanation of risk groups. Created with permission from reference 6 © (1997) American Society of Hematology. | ||
| Low | 0 | 5.7 |
| INT-1 | 0.5–1.0 | 3.5 |
| INT-2 | 1.5–2.0 | 1.2 |
| High |  2.5 | 0.4 |
